arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Cyclerion Therapeutics, Inc.

CYCN

$3.73 ▲ +0.13 (+3.61%) at close

34 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Cyclerion Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $15.7M

Dividend Yield —

Revenue Growth N/M

Op. Margin None

ROIC -37.3% ↘

FCF / Share $-0.30

Trailing P/E —

Price / Book 2.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

34-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-3.18M

↓ -122.3% —

Operating Margin Operating profit as % of sales

-81.8%

↑ +28.9% 0th

FCF / Share Free cash flow per share

$-0.30

↑ +22.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	N/M	-43.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-641%)	351.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4288%)	—	—	—	—	—	—	—	—	N/M	N/M	N/M	N/M	-89.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1222%)	1046.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+12985%)	300.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3659%)	-13.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-262%)	300.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3657%)	-93.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1274%)	-91.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1238%)	-71.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-992%)	-54.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-775%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-35.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-3.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	79.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	9.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	71.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-287.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	78.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	-490.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	—	-1283.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	7.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	31.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-122.3% Weak ↓ Weak Declining Year-over-year change in net income	N/M	7.3% Fair → Fair Stable Year-over-year change in net income	7.3% Fair ↓ Fair Declining Year-over-year change in net income	7.3% Fair ↓ Fair Declining Year-over-year change in net income	N/M	77.8% Excellent → Excellent Stable Year-over-year change in net income	77.8% Excellent ↑ Excellent Improving Year-over-year change in net income	77.8% Excellent ↑ Excellent Improving Year-over-year change in net income	76.5% Excellent ↑ Excellent Improving Year-over-year change in net income	46.4% Excellent ↑ Excellent Improving Year-over-year change in net income	46.4% Excellent ↑ Excellent Improving Year-over-year change in net income	46.4% Excellent ↑ Excellent Improving Year-over-year change in net income	33.0% Excellent ↑ Excellent Improving Year-over-year change in net income	3.1% Caution ↓ Caution Declining Year-over-year change in net income	3.1% Caution ↓ Caution Declining Year-over-year change in net income	3.1% Caution ↓ Caution Declining Year-over-year change in net income	44.0% Excellent ↑ Excellent Improving Year-over-year change in net income	33.8% Excellent ↑ Excellent Improving Year-over-year change in net income	33.8% Excellent ↑ Excellent Improving Year-over-year change in net income	33.8% Excellent ↑ Excellent Improving Year-over-year change in net income	26.2% Excellent ↓ Excellent Declining Year-over-year change in net income	26.0% Excellent ↓ Excellent Declining Year-over-year change in net income	37.3% Excellent ↑ Excellent Improving Year-over-year change in net income	45.9% Excellent ↑ Excellent Improving Year-over-year change in net income	15.7% Good ↑ Good Improving Year-over-year change in net income	6.7% Fair ↑ Fair Improving Year-over-year change in net income	-8.3% Weak Weak Year-over-year change in net income	-47.9% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	22.0% Good Good Year-over-year change in free cash flow	—	—	—	49.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	-32.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-51.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	50.2% Excellent Excellent Compound annual revenue growth over 3 years	-17.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	-42.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	50.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	16.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-34.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-39.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	4.0% Fair Fair Compound annual revenue growth over 5 years	-32.6% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	—	-81.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-645%)	-115.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-866%)	—	—	27.8% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+85%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	-78.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-750%)	-163.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1461%)	—	—	29.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+145%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-446.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3822%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	-154.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-30.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	19.9% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	-183.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.98x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.21x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.51x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-37.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-15.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.5% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-65.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-141.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-21.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	380.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	233.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	284.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	273.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	233.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-37.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	5.2% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-12.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-61.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-24.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-13.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-382.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-417.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-46.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	-8.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-15.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-16.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-16.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	6.0% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-60%)	-18.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-17.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	-15.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-15.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-54.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-460%)	-135.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1000%)	-177.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1281%)	-69.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-560%)	-78.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-624%)	-51.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-441%)	-35.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-334%)	-22.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-249%)	-23.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-20.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-27.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-284%)	-32.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-315%)	-26.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-279%)	-30.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-304%)	-24.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-26.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	-22.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-22.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	—	295.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1872%)	—	—	295.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1867%)	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-2.82M	$-3.24M	$-4.57M	$-3.01M	$-3.64M	$-3.23M	$-2.87M	$-4.59M	$-5.70M	$-7.57M	$-9.11M	$-5.64M	$-7.17M	$-13.38M	$-20.41M	$-30.32M	$-41.12M	$-53.96M	$-62.50M	$-70.39M	$-41.43M	$-54.40M	$-63.34M	$-56.46M	$-67.10M	$-94.89M	$-117.03M	$-141.03M	—	—	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.16x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$0.00	—	$0.27	$0.03	$0.03	—	$0.08	—	—	—	$0.00	$0.00	—	—	$0.00	$0.01	—	—	$0.01	$0.08	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.76	$-0.19	$-0.30	$-0.11	$-0.56	$0.22	$-0.29	$-0.53	$-0.62	$-0.70	$3.11	$-1.83	$-0.16	$-3.32	$-0.24	$-0.31	—	$-0.24	$-0.26	$-0.45	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.30	—	$-0.08	$-0.16	$-0.38	—	—	—	$-0.75	—	—	—	—	—	—	—	—	—	$-0.18	$-0.15	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.60	$2.38	$2.58	$2.79	$2.87	$3.48	$3.24	$3.49	$3.97	$4.56	$5.26	$2.14	$0.09	$4.80	$0.38	$0.58	$0.85	$1.11	$1.30	$1.83	$1.42	—	$2.22	$2.37	$2.94	$3.54	$4.34	$5.15	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$1.60	$2.38	$2.58	$2.79	$2.87	$3.48	$3.24	$3.49	$3.97	$4.56	$5.26	$2.14	$0.09	$4.80	$0.38	$0.58	$0.85	$1.11	$1.30	$1.83	$1.42	—	$2.22	$2.37	$2.94	$3.54	$4.34	$5.15	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	4.21M	—	3.23M	3.07M	2.56M	—	2.53M	2.51M	2.49M	—	2.44M	2.28M	43,521	—	43.49M	43.46M	—	—	43.29M	35.71M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$1.38M	$3.73M	$4.19M	$3.22M	$3.43M	$3.50M	$2.85M	$3.43M	$4.57M	$5.94M	$7.52M	$2.17M	$804.00K	$7.19M	$13.13M	$21.83M	$33.34M	$44.37M	—	—	$30.98M	$41.55M	$53.86M	$43.92M	$58.69M	$82.95M	$101.61M	$122.78M	$-16.53M	$-16.97M	—	—	—	—
Total Equity (USD)	$6.79M	$9.09M	$9.54M	$8.57M	$8.78M	$8.85M	$8.20M	$8.78M	$9.92M	$11.29M	$12.87M	$5.15M	$3.92M	$10.45M	$16.52M	$25.36M	$37.03M	$48.25M	$56.39M	$65.22M	$48.43M	$59.49M	$75.35M	$66.10M	$81.54M	$97.73M	$119.20M	$141.19M	$-7.75M	$-10.45M	$-8.12M	$-8.61M	$-8.57M	$-8.57M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$1.02M	$875.00K	$93.00K	$81.00K	$1.81M	$194.00K	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$306.00K	$711.00K	$533.00K	$348.00K	$3.00M	$62.00K	$133.00K	$400.00K	$749.00K	$1.01M	$1.48M	$1.40M	$1.63M	—	—	—	—	—	—
Net Income, GAAP (USD)	$-3.18M	$-799.00K	$-1.43M	$-1.43M	$-1.43M	$530.00K	$-1.54M	$-1.54M	$-1.54M	$-1.69M	$-6.95M	$-6.95M	$-6.95M	$-7.22M	$-12.98M	$-12.98M	$-12.98M	$-10.78M	$-13.40M	$-13.40M	$-13.40M	$-19.23M	$-20.23M	$-20.23M	$-20.23M	$-26.05M	$-27.32M	$-32.25M	$-37.38M	$-30.90M	$-29.29M	$-29.78M	$-25.28M	—
Operating Cash Flow (USD)	$-1.18M	$-1.58M	$-264.00K	$-503.00K	$-968.00K	$360.00K	—	—	$-1.87M	$-1.54M	—	—	$-6.21M	$-7.04M	—	—	$-12.84M	$-8.63M	$-7.92M	$-5.51M	$-14.46M	$-14.04M	—	—	$-29.18M	$-22.16M	—	—	$-34.27M	$-23.15M	$-25.30M	$-22.62M	$-26.43M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters

Cyclerion Therapeutics, Inc.

Analytical Summary

34-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CYCN with peers